Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy
26 nov. 2024 08h05 HE
|
Tevogen Bio Inc
WARREN, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...